av/caplin-point-laboratories--big.svg

NSE:CAPLIPOINT

Caplin Point Laboratories Limited

  • Stock

1,878.20

−0.04%

−0.70

INR last updated 28/07 01:48:46

Last Close

1,878.90

02/05 08:51

Market Cap

115.32B

Beta: 0.37

Volume Today

64.14K

Avg: 105.40K

PE Ratio

25.48

PFCF: 2,052.18

Dividend Yield

0.32%

Payout:0%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized prod...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    510152019-12-312021-03-302022-03-302023-08-082024-08-05

    Revenue (Estimate*)

    1B2B3B4B5B2019-12-312021-03-302022-03-302023-08-082024-08-05

    *Estimate based on analyst consensus